Rural Health
Resources by Topic: Illicit drug use
A Qualitative Study on Pharmacy Policies Toward Over-the-Counter Syringe Sales in a Rural Epicenter of US Drug-Related Epidemics
Examines pharmacy over-the-counter (OTC) policies and pharmacists' rationale for, and barriers and facilitators to, OTC syringe sales in a rural Appalachian Kentucky area hard hit by drug-related epidemics. Uses data collected from interviews with 14 pharmacists between February 2018 and January 2019.
Author(s): Monica Fadanelli, Hannah L. F. Cooper, Patricia R. Freeman, et al.
Citation: Harm Reduction Journal, 19(1)
Date: 01/2022
view details
Examines pharmacy over-the-counter (OTC) policies and pharmacists' rationale for, and barriers and facilitators to, OTC syringe sales in a rural Appalachian Kentucky area hard hit by drug-related epidemics. Uses data collected from interviews with 14 pharmacists between February 2018 and January 2019.
Author(s): Monica Fadanelli, Hannah L. F. Cooper, Patricia R. Freeman, et al.
Citation: Harm Reduction Journal, 19(1)
Date: 01/2022
view details
Rural and Urban Differences in Undersupply of Buprenorphine Provider Availability in the United States, 2018
Presents a study comparing county-level rates of providers with buprenorphine waivers with rates of opioid-overdose deaths and compares rural and urban areas. Details rural and urban comparisons for 38 states.
Author(s): Kevin P. Conway, Dalia Khoury, Rainer Hilscher, et al.
Citation: Addiction Science and Clinical Practice, 17, 5
Date: 01/2022
view details
Presents a study comparing county-level rates of providers with buprenorphine waivers with rates of opioid-overdose deaths and compares rural and urban areas. Details rural and urban comparisons for 38 states.
Author(s): Kevin P. Conway, Dalia Khoury, Rainer Hilscher, et al.
Citation: Addiction Science and Clinical Practice, 17, 5
Date: 01/2022
view details
Changes in Access to Medication Treatment during COVID-19 Telehealth Expansion and Disparities in Telehealth Use for Medicare Beneficiaries with Opioid Use Disorder
Discusses policies that allow access to medication for opioid use disorder (MOUD) via telehealth before and during the COVID-19 pandemic. Examines outpatient telehealth use and MOUD treatment among Medicare beneficiaries by dual eligibility status, rurality, and presence of comorbid health conditions between April-December 2020.
Date: 01/2022
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Discusses policies that allow access to medication for opioid use disorder (MOUD) via telehealth before and during the COVID-19 pandemic. Examines outpatient telehealth use and MOUD treatment among Medicare beneficiaries by dual eligibility status, rurality, and presence of comorbid health conditions between April-December 2020.
Date: 01/2022
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Rural Community Health Initiative: Compendium of Best Practices
Presents a collection of community-based health initiatives, including a school health initiative, a COVID-19 vaccine outreach and education program, and telehealth consortia, among others. Describes successful outcomes and sources of funding for each program.
Date: 01/2022
Sponsoring organization: National Rural Health Association
view details
Presents a collection of community-based health initiatives, including a school health initiative, a COVID-19 vaccine outreach and education program, and telehealth consortia, among others. Describes successful outcomes and sources of funding for each program.
Date: 01/2022
Sponsoring organization: National Rural Health Association
view details
Outcomes from the Medication Assisted Treatment Pilot Program for Adults with Opioid Use Disorders in Rural Colorado
Examines the efficacy of a medication for opioid use disorder (MOUD) pilot program in two rural Colorado counties. Details the structure and setting of the program, patient characteristics and outcomes, and the limitations of the program.
Author(s): Claudia R. Amura, Tanya R. Sorrell, Mary Weber, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 17(1)
Date: 01/2022
view details
Examines the efficacy of a medication for opioid use disorder (MOUD) pilot program in two rural Colorado counties. Details the structure and setting of the program, patient characteristics and outcomes, and the limitations of the program.
Author(s): Claudia R. Amura, Tanya R. Sorrell, Mary Weber, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 17(1)
Date: 01/2022
view details
Risk Factors for Adolescent Drug and Alcohol Abuse in Arkansas 2022
Provides state, region, and county-level data for Arkansas related to substance abuse by youth. Identifies risk factors associated with drug and alcohol abuse, such as the number of arrests, unemployment, school infractions, and more, as well as associated public health outcomes.
Date: 2022
Sponsoring organizations: Arkansas Department of Human Services, Arkansas Foundation for Medical Care, UA Little Rock MidSOUTH Center for Prevention and Training
view details
Provides state, region, and county-level data for Arkansas related to substance abuse by youth. Identifies risk factors associated with drug and alcohol abuse, such as the number of arrests, unemployment, school infractions, and more, as well as associated public health outcomes.
Date: 2022
Sponsoring organizations: Arkansas Department of Human Services, Arkansas Foundation for Medical Care, UA Little Rock MidSOUTH Center for Prevention and Training
view details
Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop
Offers proceedings from the March 2022 workshop, Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws. Covered topics include personal perspectives on methadone treatment, access and barriers to access for rural and other underserved populations, and federal policies and regulatory flexibilities during the COVID-19 pandemic.
Additional links: Read Online
Author(s): Board on Health Sciences Policy, Board on Health Care Services
Date: 2022
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Offers proceedings from the March 2022 workshop, Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws. Covered topics include personal perspectives on methadone treatment, access and barriers to access for rural and other underserved populations, and federal policies and regulatory flexibilities during the COVID-19 pandemic.
Additional links: Read Online
Author(s): Board on Health Sciences Policy, Board on Health Care Services
Date: 2022
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
State Policy Changes Could Increase Access to Opioid Treatment via Telehealth
Issue brief discussing barriers to opioid use disorder (OUD) treatment via telehealth and policy recommendations to support telehealth, including reimbursement and regulatory policies. Discusses issues of broadband access, infrastructure, and data collection in relation to telehealth implementation.
Date: 12/2021
Sponsoring organization: Pew Charitable Trusts
view details
Issue brief discussing barriers to opioid use disorder (OUD) treatment via telehealth and policy recommendations to support telehealth, including reimbursement and regulatory policies. Discusses issues of broadband access, infrastructure, and data collection in relation to telehealth implementation.
Date: 12/2021
Sponsoring organization: Pew Charitable Trusts
view details
Opioid Use Disorder: Opportunities to Improve Assessments of State Opioid Response Grant Program
Provides an overview of the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response (SOR) grant program and examines how SAMHSA assesses the program. Offers recommendations to SAMHSA to identify potential limitations in its analyses and provide a more comprehensive assessment of the program to identify opportunities for improvement. Includes SOR grant funding awards by state for fiscal years 2020 and 2021.
Additional links: Full Report
Date: 12/2021
Sponsoring organization: Government Accountability Office
view details
Provides an overview of the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response (SOR) grant program and examines how SAMHSA assesses the program. Offers recommendations to SAMHSA to identify potential limitations in its analyses and provide a more comprehensive assessment of the program to identify opportunities for improvement. Includes SOR grant funding awards by state for fiscal years 2020 and 2021.
Additional links: Full Report
Date: 12/2021
Sponsoring organization: Government Accountability Office
view details
A Cross-Sectional Survey of Potential Factors, Motivations, and Barriers Influencing Research Participation and Retention Among People Who Use Drugs in the Rural USA
Study examining research participation and retention among rural people who use drugs (PWUD) based on surveys of 255 research cohort members from Oregon, Kentucky, and Ohio. Examines participant demographics, drug use history, factors influencing research participation, and barriers and motivators related to research retention.
Author(s): Angela T. Hetrick, April M. Young, Miriam R. Elman, et al.
Citation: Trials, 22, 948
Date: 12/2021
view details
Study examining research participation and retention among rural people who use drugs (PWUD) based on surveys of 255 research cohort members from Oregon, Kentucky, and Ohio. Examines participant demographics, drug use history, factors influencing research participation, and barriers and motivators related to research retention.
Author(s): Angela T. Hetrick, April M. Young, Miriam R. Elman, et al.
Citation: Trials, 22, 948
Date: 12/2021
view details